Genomic Biomarker Market is expected to increase at a compound annual growth rate (CAGR) of 11.6% from 2025 to 2035
The genomic biomarker market is expected to increase at a compound annual growth rate (CAGR) of 11.6% from 2025 to 2035, from its estimated USD 26.78 billion in 2024 to USD 89.56 billion. In the field of personalized medicine, which aims to maximize therapeutic approaches and minimize adverse effects by understanding each individual's unique genetic composition, the idea of genomic biomarkers has grown in popularity. A DNA or RNA feature that indicates normal biological processes, pathogenic processes, and/or responsiveness to therapeutic or other interventions is called a genomic biomarker. These measurable factors predict therapy responses, provide quantifiable evidence of treatment efficacy, or reveal hereditary vulnerability to the disease. Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/genomic-biomarker-market GROWTH DRIVERS Genetic testing for cancer, uncommon diseases, and inherited disorders is becoming more comm...